Care strategies for the elderly with benign prostatic hyperplasia: an integrative literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v11i1.18310

Keywords:

Elderly; Benign prostatic hyperplasia; LUTS.

Abstract

Objective: Demonstrate, through an Interactive Literature Review, care strategies for elderly patients with Benign Prostatic Hyperplasia (BPH). Methods: This is an Integrative Literature Review (RIL) study, with data collection through online access in Cochrane Library databases and databases; PubMed, Cochrane Library and VHL. After evaluating and synthesizing the articles, the data were analyzed using the IraMuTeQ software, presenting the results through the similarity analysis with the identification of co-occurrences between the words and indications of the connection. Results/Discussion: From the results obtained through the co-occurrence tree, 3 classes were divided: The prevalence of the relationship between HBP and LUTS as a way of detecting diseases; Evaluation of the elderly population with BPH as a way to identify limitation, cause or condition that reduces the effectiveness and effect of the treatment.; Interventions for BPH symptoms in the elderly. Conclusion: It is observed that care strategies for elderly people with Benign Prostatic Hyperplasia are still scarce, limiting pharmacological and behavioral interventions. The assessment of the specificities of this population is presented as a way to monitor the results from the treatments, in addition to adverse effects related to avoiding the worsening of the condition.

References

Alawamlh, O. A. H., Goueli, R., & Lee, R. K. (2018). Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, and Urinary Retention. Med Clin North Am; 102(2): 301-11.https://www.ncbi.nlm.nih.gov/pubmed/29406059

Bitencourt, G. R., Felippe, N. H. M. D., & Santana, R. F. (2016). Diagnóstico de enfermagem eliminação urinária prejudicada em idosos no pós-operatório: um estudo transversal. Rev enferm UERJ, 24(3). https://www.e-publicacoes.uerj.br/index.php/enfermagemuerj/article/view/16629.

Barbosa, J. A., & Antunes, A. (2018). Técnicas minimamente invasivas para o tratamento da hiperplasia prostática benigna. Revista De Medicina, 97(3), 314-319. https://doi.org/10.11606/issn.1679-9836.v97i3p314-319

Bortnick, E. M., Simma-chiang, V., & Kaplan, A. S. (2019). Long-term Consequences of Medical Therapy for Benign Prostatic Hyperplasia. Reviews in Urology 21(4). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020283/.

Cureklibatir, I., & Kizilay, F. (2015). Prostate Gland and its Diseases. Ege University Public Books Series; 18.

Dai, X. et al. (2016). “Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.” Medicine 95(18). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863764/

Farias, T. L. F., & Castillo, L. A. C. (2020). Assistência de enfermagem ao portador de câncer de próstata noserviço de urgência/emergência: uma revisão bibliográfica. Revista Científica Educandi & Civitas, 3(1) http://162.241.180.121/~educandiecivitas/index.php/educandiecivitas/article/view/38.

Kuo, Y. J. et al. (2019). Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study. Cancer Medicine. 1–10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536940/.

Lee, Y. C. et al. (2016). The association of endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with responsiveness to a selective a1-blocker in men with benign prostatic hyperplasia related lower urinary tract symptoms. BJU Int. 118(2):313-9. https://www.ncbi.nlm.nih.gov/pubmed/26940040.

Lee, H. Y. et al. (2020). Moxibustion as an adjunct for lower urinary tract symptoms associated with benign prostate enlargement: a randomized controlled pilot trial. Medicine, 99:4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004691/

Lokant M, & Naz, R. (2015). Presence of PSA autoantibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis). Andrologia; 47: 328- 332. https://pubmed.ncbi.nlm.nih.gov/24620795/

Marchand P, & Ratinaud P. (2012). L'analyse de similitude appliqueé aux corpus textueles: les primaires socialistes pour l'election présidentielle française. Em: Actes des 11eme Journées internationales d’Analyse statistique des Données Textuelles. JADT 2012. (687–699).

Oxford Centre for Evidence-Based Medicine. (2009). Levels of evidence [Internet]. Recuperado em:http://www.cebm.net/oxfordcentre-evidence-based-medicine-levels- evidencemarch-2009.

Park, J. S. et al. (2019). Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population. Medicine; 98:42. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824778/

Parsons, J. K., et al. (2013). Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. The Journal of Urology, 189, S102-S106. https://pubmed.ncbi.nlm.nih.gov/23234610/

Rył, A et al. (2015). “Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?.” Diabetology & metabolic syndrome 7(94). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625953/.

Santos C. M. B., et al. (2018). Sistematização da assistência de enfermagem a pessoa idosa portadora de hiperplasia prostática benigna: relato de experiência. In: Congresso Internacional de Envelhecimento Humano, 5, 2017, Maceió. Anais. Alagoas, Editora realize.

Shih, H. J. et.al. (2017). Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia. The Prostate. 1–8. https://www.ncbi.nlm.nih.gov/pubmed/29119583.

Shore N. (2015). A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic Hyperplasia. Current bladder dysfunction reports. 10(2): 186-192. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424373/

Teixeira, I. D. Sanches, A. M. & Falcão, G. (2017). Um caso clínico de sintomas Urinários baixos. Ver Port Med Geral Fam; 33:134-40. https://www.rpmgf.pt/ojs/index.php/rpmgf/article/view/12041

Wroclawski M. L, Carneiro A, Tristão R. A., Sakuramoto P. K.., Youssef J D., Lopes Neto A. C., Santiago L. H., & Pompeo A. C. (2016). Giant prostatic hyperplasia: report of a previously asymptomatic man presenting with gross hematuria and hypovolemic shock. Einstein.;1-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943789/.

Downloads

Published

04/01/2022

How to Cite

CARVALHO , D. de N. R. de; DERGAN, M. R. A.; LIMA, P. A. V. .; SILVA, T. F. da .; PEREIRA, L. de J.; TAVARES, N. K. C. .; FERREIRA, L. G. S. .; CARNEIRO, D. M. M. .; BORGES, N. K. C. .; MACIEL, C. M.; COSTA, F. de N. A. .; SOUZA, D. M. de .; DAMACENO, A. C. M.; OLIVEIRA, M. S. .; SANTOS, C. C. dos .; SILVA, L. G. S. da; BAIA, M. L. S. de S.; SANTOS, Y. de L. M. dos; SANTOS, D. de N. dos .; DUTRA, T. da S.; ORLANDI, F. de S. . Care strategies for the elderly with benign prostatic hyperplasia: an integrative literature review. Research, Society and Development, [S. l.], v. 11, n. 1, p. e17511118310, 2022. DOI: 10.33448/rsd-v11i1.18310. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/18310. Acesso em: 22 nov. 2024.

Issue

Vol. 11 No. 1

Section

Review Article

License

Copyright (c) 2022 Dayara de Nazaré Rosa de Carvalho ; Marcela Raíssa Asevedo Dergan; Paula Andreza Viana Lima; Tainan Fabrício da Silva; Lucas de Jesus Pereira; Natalie Kesle Costa Tavares; Layana Giselly Silva Ferreira; Danielle Maria Martins Carneiro; Nathila Keith Camara Borges; Camila Medeiros Maciel; Fernanda de Nazaré Almeida Costa; Daniele Moura de Souza; Ana Carolina Martins Damaceno; Miriam Souza Oliveira; Charles Carvalho dos Santos; Larissa Graziela Sousa da Silva; Monique Lindsy Silva de Souza Baia; Yves de Luka Miranda dos Santos; Dayanne de Nazaré dos Santos; Tamires da Silva Dutra; Fabiana de Souza Orlandi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.